Showing results (341-350 of 3,539) with videos related to
Sort By:
Pageof 354
Chemical Biology & Drug Design|October 17, 2007
Signposts of docking and scoring in drug designOsman A B S M GaniChemical Biology & Drug Design|August 9, 2007
The discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an orally efficacious factor Xa inhibitorJeffrey T Kohrt, Christopher F Bigge, John W Bryant, et al.Chemical Biology & Drug Design|August 9, 2007
Evaluating different descriptors for model design of antimicrobial peptides with enhanced activity toward P. aeruginosaHåvard Jenssen, Tore Lejon, Kai Hilpert, et al.Chemical Biology & Drug Design|February 23, 2007
Synthesis and biological activity of a focused library of mitogen-activated protein kinase phosphatase inhibitorsDavid M Arnold, Caleb Foster, Donna M Huryn, et al.Chemical Biology & Drug Design|February 23, 2007
A structure-based, quantitative structure-activity relationship approach for predicting HLA-A*0201-restricted cytotoxic T lymphocyte epitopesPeng Zhou, Feifei Tian, Zhiliang LiChemical Biology & Drug Design|February 23, 2007
Molecular conceptor for training in medicinal chemistry, drug design, and cheminformaticsClaude Cohen, Ouri Fischel, Elie CohenChemical Biology & Drug Design|March 27, 2007
De novo design of DeltaF -containing heme-binding peptidesJagdish Rai, S Raghothama, D SahalChemical Biology & Drug Design|November 16, 2006
A chemical genetic screen for cell cycle inhibitors in zebrafish embryosRyan D Murphey, Howard M Stern, Christian T Straub, et al.Chemical Biology & Drug Design|November 18, 2008
Helical peptides derived from lactoferrin bind hepatitis C virus envelope protein E2Reem Beleid, Donna Douglas, Norman Kneteman, et al.Chemical Biology & Drug Design|July 1, 2009
Pharmacophore identification and validation study of CK2 inhibitors using CoMFA/CoMSIAMohammad Neaz Morshed, Muhammad Muddassar, Farhan Ahmad Pasha, et al.Pageof 354